- Home
- TIVC vs APVO Comparison
TIVC vs APVO Comparison
Compare TIVC & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIVC
- APVO
- Stock Information
- Founded
- TIVC 2016
- APVO 2016
- Country
- TIVC United States
- APVO United States
- Employees
- TIVC N/A
- APVO N/A
- Industry
- TIVC Biotechnology: Electromedical & Electrotherapeutic Apparatus
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- TIVC Health Care
- APVO Health Care
- Exchange
- TIVC Nasdaq
- APVO Nasdaq
- Market Cap
- TIVC 4.0M
- APVO 4.1M
- IPO Year
- TIVC 2021
- APVO N/A
- Fundamental
- Price
- TIVC $3.22
- APVO $2.02
- Analyst Decision
- TIVC
- APVO Strong Buy
- Analyst Count
- TIVC 0
- APVO 1
- Target Price
- TIVC N/A
- APVO $5,920.00
- AVG Volume (30 Days)
- TIVC 2.3M
- APVO 134.2K
- Earning Date
- TIVC 08-14-2025
- APVO 08-11-2025
- Dividend Yield
- TIVC N/A
- APVO N/A
- EPS Growth
- TIVC N/A
- APVO N/A
- EPS
- TIVC N/A
- APVO N/A
- Revenue
- TIVC $462,000.00
- APVO N/A
- Revenue This Year
- TIVC N/A
- APVO N/A
- Revenue Next Year
- TIVC N/A
- APVO N/A
- P/E Ratio
- TIVC N/A
- APVO N/A
- Revenue Growth
- TIVC N/A
- APVO N/A
- 52 Week Low
- TIVC $2.43
- APVO $1.72
- 52 Week High
- TIVC $15.64
- APVO $381.10
- Technical
- Relative Strength Index (RSI)
- TIVC 40.16
- APVO 29.31
- Support Level
- TIVC $3.39
- APVO $1.72
- Resistance Level
- TIVC $5.60
- APVO $2.20
- Average True Range (ATR)
- TIVC 0.38
- APVO 0.18
- MACD
- TIVC 0.01
- APVO 0.01
- Stochastic Oscillator
- TIVC 4.80
- APVO 22.58
About TIVC Tivic Health Systems Inc.
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.